Management of externally manufactured cell therapy products: the Mayo Clinic approach.
Sign Up to like & getrecommendations! Published in 2022 at "Cytotherapy"
DOI: 10.1016/j.jcyt.2020.12.013
Abstract: BACKGROUND The rise of investigative and commercially available cell therapy products adds a new dynamic to academic medical centers; that is, the management of patient-specific cell products. The scope of cell therapy has rapidly expanded… read more here.
Keywords: externally manufactured; therapy products; cell; mayo clinic ... See more keywords
Delivering externally manufactured cell and gene therapy products to patients: perspectives from the academic center experience.
Sign Up to like & getrecommendations! Published in 2021 at "Cytotherapy"
DOI: 10.1016/j.jcyt.2021.09.010
Abstract: The recent success of the commercialization of CAR-T and other immune effector cells has led to the rapid expansion of clinical trials using cellular therapy products. The expansion of both investigational and commercially available cell… read more here.
Keywords: center; externally manufactured; therapy products; therapy ... See more keywords